Leading Companies

Alpha-O Peptides AG

Alpha-O Peptides AG (“AOP”) is a Swiss nano-biotechnology company focusing on the development of potent vaccines based on repetitive antigen display technology using our proprietary and patented self-assembling protein nanoparticles (SAPNs). AOP’s most advanced vaccine has demonstrated complete protection against malaria infection in an animal model. The National Institutes of Health (NIH) and the U.S. Military Infectious Disease Research Program have both supported this project.

Alpha-O Peptides AG

Lörracherstrasse 50
4125 Riehen

Swiss Tech + Industries
Life Science
Bio Technology (Biotech)
Country of Origin

Premium Partner

Strategische Partner

Institutioneller Partner

Official program